{"title":"A practical approach to high-risk foreign body ingestion in children","authors":"Sarah Stibbards","doi":"10.1016/j.paed.2025.05.001","DOIUrl":"10.1016/j.paed.2025.05.001","url":null,"abstract":"<div><div>Children commonly present with a history of witnessed or unwitnessed ingested foreign body (FB). Most are low risk objects, with the child or young person remaining asymptomatic enabling management without imaging or intervention. However, there are a several high-risk objects and clinical scenarios where it is important to have high clinical suspicion as they can cause serious injury if they remain in the gastrointestinal tract. Such injuries include oesophageal obstruction, perforation, fistulae into surrounding structures e.g. trachea, blood vessels, and bowel obstruction or perforation and can lead to long term complications or death. Button battery ingestion is particularly dangerous as necrosis, erosion and perforation can occur within hours and even after the battery has been removed, serious complications can still develop days, weeks, or months later. Currently there is not enough research to agree a standard approach following the ingestion of all FBs. This article aims to allow clinicians to follow a standardised approach and enact safe management of ingested FBs in children, whilst avoiding unnecessary investigation or ionising radiation. It includes guidance on which patients can go home safely without investigation or follow-up, which patients require investigations and which patients require emergent or urgent intervention by specialty teams.</div></div>","PeriodicalId":38589,"journal":{"name":"Paediatrics and Child Health (United Kingdom)","volume":"35 7","pages":"Pages 221-226"},"PeriodicalIF":0.0,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144481712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Point-of-care ultrasound in paediatric clinical practice: transforming tomorrow today","authors":"David J McCreary, Niall Mullen","doi":"10.1016/j.paed.2025.05.003","DOIUrl":"10.1016/j.paed.2025.05.003","url":null,"abstract":"<div><div>Point-of-care ultrasound (POCUS) has emerged as a valuable tool for clinicians. It is best considered as an extension of the clinical assessment, where it can provide greater information than is available via traditional physical examination alone. POCUS fulfils several roles within clinical paediatrics; most commonly it serves as a diagnostic aid, helping to further a clinician's working hypothesis by excluding less likely diagnoses or helping to improve certainty in confirming others. Its use can obviate the need for other investigations such as blood tests and in doing so it can streamline the patient journey. In certain scenarios POCUS can fulfil the role that a conventional imaging investigation has done previously. It has emerged as a tool to guide resuscitation and stabilization of the seriously unwell patient and, as is perhaps most familiar, it can be used to help guide procedures. The aim of this article is to summarize the current applications of POCUS in acute paediatric care as well as to highlight more novel, emerging applications.</div></div>","PeriodicalId":38589,"journal":{"name":"Paediatrics and Child Health (United Kingdom)","volume":"35 7","pages":"Pages 234-240"},"PeriodicalIF":0.0,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144481774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Post COVID-19 paediatric inflammatory syndrome (PIMS-TS/MIS-C): what have we learned?","authors":"David Reynolds, Patrick Davies","doi":"10.1016/j.paed.2025.05.005","DOIUrl":"10.1016/j.paed.2025.05.005","url":null,"abstract":"<div><div>During the early phase of the COVID-19 pandemic, PIMS-TS emerged as a new hyper-inflammatory disorder affecting children. These children were often unstable requiring admission to critical care. Children with PIMS-TS displayed symptoms mimicking other inflammatory processes but it was quickly apparent this was a novel condition requiring its own treatment regime. Through international co-operative resource sharing, agreement grew over several treatment options including biological agents, IVIG and steroids leading to consensus guidance based on anecdotal and limited observed data. As our understanding of COVID-19 grew with each wave of the pandemic, so has our understanding of PIMS-TS. Several large trials, including the RECOVERY and BATS trials, are now able to provide an evidence base for the treatment of this condition, and challenge some of the management practices that were widely utilized. IV Immunoglobulin, for example, has been shown not to change outcomes and would therefore no longer be recommended for treatment, whereas methylprednisolone did show some improvements over usual supportive care. Epidemiology data shows PIMS-TS to have been a temporally limited condition, reducing in prevalence with each variant of COVID-19. Looking at overall outcome data, this was thankfully a condition with overall very low mortality and limited long term morbidity.</div></div>","PeriodicalId":38589,"journal":{"name":"Paediatrics and Child Health (United Kingdom)","volume":"35 7","pages":"Pages 247-252"},"PeriodicalIF":0.0,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144481772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"How to interpret creatine kinase level in neuromuscular conditions","authors":"Nermin Alashal, Nahin Hussain","doi":"10.1016/j.paed.2025.05.004","DOIUrl":"10.1016/j.paed.2025.05.004","url":null,"abstract":"<div><div>Creatine kinase (CK) is a screening diagnostic test for suspected neuromuscular disease. It is a sensitive indicator of muscle injury and is preferred to other skeletal muscle enzymes as it is least affected by haemolysis, is readily released in cellular injury and has a relative predominance in skeletal muscle. In a healthy individual the normal range varies between 22 and 200 IU/L (varies with laboratory), although gender and race can influence this range. CK can also be elevated in non-pathological transient situations such as cramps and post-exercise. It can increase up to three times the normal value after strenuous exercise, intramuscular injections, EMG studies and viral infections. Highest level of CK is seen in inflammatory myopathies and in early stages of DMD when patients are still ambulant. Occasionally CK is elevated in asymptomatic or mildly symptomatic children and this creates unwarranted anxiety and diagnostic uncertainties. The need for extensive ancillary investigations and muscle biopsy in clinically normal individuals with elevated CK remains an unresolved issue. This review discusses the diagnostic value of creatine kinase in neuromuscular conditions in children and offers practical advice about how results should be interpreted in different clinical situations.</div></div>","PeriodicalId":38589,"journal":{"name":"Paediatrics and Child Health (United Kingdom)","volume":"35 7","pages":"Pages 241-246"},"PeriodicalIF":0.0,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144481713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"From inquisitive toddlers to adventurous teenagers: how to navigate paediatric minor injuries","authors":"Melissa Leadbetter, Laura Duthie","doi":"10.1016/j.paed.2025.05.002","DOIUrl":"10.1016/j.paed.2025.05.002","url":null,"abstract":"<div><div>Paediatric minor injuries are a frequent presentation to the Emergency Department (ED) and acute care settings. As children develop from curious pre-schoolers to teenagers who are learning to take risks, the pattern of injury changes from lower impact injuries and foreign body insertion or ingestions, to injuries sustained at higher impact. Paediatricians typically receive little training in minor injuries. However, some injuries are seen more commonly in children, therefore knowledge or experience in managing them may also be lacking for clinicians who are primarily trained in adult emergency care. Effective management not only requires a comprehensive understanding of paediatric anatomy and physiology, but a nuanced approach to management, tailored to the developmental needs of the child. This can often be a challenge and techniques used in an older child or adult may not be appropriate. This article provides a practical guide to the assessment, diagnosis, and treatment of common minor injuries in Paediatrics. Including some helpful tips and tricks on how to manage those tricky customers.</div></div>","PeriodicalId":38589,"journal":{"name":"Paediatrics and Child Health (United Kingdom)","volume":"35 7","pages":"Pages 227-233"},"PeriodicalIF":0.0,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144481773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Managing difficult intravenous access: obtaining and maintaining paediatric vascular access","authors":"Wei Yen Evelyn Chia","doi":"10.1016/j.paed.2025.04.002","DOIUrl":"10.1016/j.paed.2025.04.002","url":null,"abstract":"<div><div>Vascular access in children is often challenging, especially in difficult intravenous access (DIVA) patients. Identifying the vascular access needed and planning insertion points carefully to maximize success and minimize patient distress is key. Although some alternative treatment options are available, a wide array of treatment care pathways are reliant on vascular access. Choosing the right vascular access device, its size and insertion point to fit the needs and condition of the patient adds complexity to decision making for the clinician. This article discusses tips for and the practicalities of obtaining and maintaining vascular access in paediatric patients, with a special focus on ultrasound-guided vascular access.</div></div>","PeriodicalId":38589,"journal":{"name":"Paediatrics and Child Health (United Kingdom)","volume":"35 6","pages":"Pages 188-195"},"PeriodicalIF":0.0,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Renal replacement therapy in the paediatric intensive care unit","authors":"Rajalakshmi Iyer, Nalaayeni Kanesan, Oluwaseun Ajayi, Arun Ghose","doi":"10.1016/j.paed.2025.04.006","DOIUrl":"10.1016/j.paed.2025.04.006","url":null,"abstract":"<div><div>Acute kidney injury (AKI) and chronic kidney disease (CKD) are significant concerns in paediatric intensive care units (PICUs), with AKI affecting up to 50% of critically ill children. Renal replacement therapy (RRT) is essential for managing these conditions, with available modalities including intermittent haemodialysis (IHD), continuous renal replacement therapy (CRRT), and peritoneal dialysis (PD). This article defines AKI and CKD based on the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines and outlines the key indications for RRT, such as severe electrolyte abnormalities, fluid overload exceeding 10%, metabolic acidosis and toxin clearance. The fundamental principles of solute clearance in RRT—including diffusion, ultrafiltration, convection, and adsorption—are explained. Additionally, the article reviews essential considerations such as vascular access, anticoagulation strategies and the unique challenges of RRT in neonates and children requiring extracorporeal life support (ECLS). CRRT allows precise and gradual solute and fluid removal, making it ideal for haemodynamically unstable patients. However, it requires an extracorporeal circuit, large-bore vascular access and anticoagulation which can pose challenges, particularly in neonates. In contrast, PD can be initiated quickly via a percutaneous catheter, avoiding the risks associated with central venous access (thrombosis and bleeding). Conversely PD solute and fluid clearance rates are less effective than CRRT, and it is unsuitable for patients with recent abdominal surgery or congenital anomalies. The choice of RRT modality depends on the child's clinical condition, available resources, and institutional expertise. This review highlights the need for individualised RRT strategies to improve outcomes and survival in critically ill children.</div></div>","PeriodicalId":38589,"journal":{"name":"Paediatrics and Child Health (United Kingdom)","volume":"35 6","pages":"Pages 196-202"},"PeriodicalIF":0.0,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"How to assess and manage headache in children: the basics","authors":"Elizabeth Liew, William P Whitehouse","doi":"10.1016/j.paed.2025.02.001","DOIUrl":"10.1016/j.paed.2025.02.001","url":null,"abstract":"<div><div>Headache in children has a wide differential, from benign, tension-type headaches to secondary headache caused by a brain tumour. We review the categories of primary and secondary headache disorders, and discuss practical approaches to the history, examination, and when to request further investigations such as brain imaging. Approaches to treatment especially of migraine and other primary headache disorders are discussed, as is service configuration. We have signposted useful resources such as NICE guidelines and quality standards, the International Headache Society's International Classification of Headache Disorders, the Migraine Trust charity, and a review of new and emerging therapies. Headache can be a terrible burden for children and worry for parents, but is a fascinating and generally rewarding field to work in.</div></div>","PeriodicalId":38589,"journal":{"name":"Paediatrics and Child Health (United Kingdom)","volume":"35 5","pages":"Pages 125-133"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143932184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Beyond valproate: considerations for the general paediatrician","authors":"Alison Skippen, Rohini Rattihalli","doi":"10.1016/j.paed.2025.02.005","DOIUrl":"10.1016/j.paed.2025.02.005","url":null,"abstract":"<div><div>Over the last year, new Medicines and Healthcare products Regulatory Agency (MHRA) regulations for the use of sodium valproate in females and males have had a significant impact on clinical practice. This article uses a case as an anchor, to understand what these regulations mean in clinical practice. We highlight that knowledge about the regulations, together with a holistic view of the patient is important to choose the most effective and tolerated medication. Professional guidelines which offer valuable support with the practicalities are highlighted in the further reading sections.</div></div>","PeriodicalId":38589,"journal":{"name":"Paediatrics and Child Health (United Kingdom)","volume":"35 5","pages":"Pages 152-154"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143932188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}